PubMed

Sulfonylurea stimulation of insulin secretion.

Proks P, Reimann F, Green N, Gribble F, Ashcroft F.

Diabetes. 2002 Dec;51 Suppl 3:S368-76. Review.PMID: 12475777 [PubMed - indexed for MEDLINE]Related articlesFree article

Differential selectivity of insulin secretagogues: mechanisms, clinical implications, and drug interactions.

Gribble FM, Reimann F.

J Diabetes Complications. 2003 Mar-Apr;17(2 Suppl):11-5. Review.PMID: 12623163 [PubMed - indexed for MEDLINE]Related articles

Stoichiometry of sulfonylurea-induced ATP-sensitive potassium channel closure.

Dörschner H, Brekardin E, Uhde I, Schwanstecher C, Schwanstecher M.

Mol Pharmacol. 1999 Jun;55(6):1060-6.PMID: 10347249 [PubMed - indexed for MEDLINE]Related articlesFree article

Sulfonylurea sensitivity of adenosine triphosphate-sensitive potassium channels from beta cells and extrapancreatic tissues.

Gribble FM, Ashcroft FM.

Metabolism. 2000 Oct;49(10 Suppl 2):3-6. Review.PMID: 11078468 [PubMed - indexed for MEDLINE]Related articles

Analysis of the differential modulation of sulphonylurea block of beta-cell and cardiac ATP-sensitive K+ (K(ATP)) channels by Mg-nucleotides.

Reimann F, Dabrowski M, Jones P, Gribble FM, Ashcroft FM.

J Physiol. 2003 Feb 15;547(Pt 1):159-68. Epub 2003 Jan 10.PMID: 12562963 [PubMed - indexed for MEDLINE]Related articlesFree article

Testing the bipartite model of the sulfonylurea receptor binding site: binding of A-, B-, and A + B-site ligands.

Winkler M, Stephan D, Bieger S, Kühner P, Wolff F, Quast U.

J Pharmacol Exp Ther. 2007 Aug;322(2):701-8. Epub 2007 May 10.PMID: 17495126 [PubMed - indexed for MEDLINE]Related articlesFree article

Control of insulin secretion by sulfonylureas, meglitinide and diazoxide in relation to their binding to the sulfonylurea receptor in pancreatic islets.

Panten U, Burgfeld J, Goerke F, Rennicke M, Schwanstecher M, Wallasch A, Zünkler BJ, Lenzen S.

Biochem Pharmacol. 1989 Apr 15;38(8):1217-29.PMID: 2650685 [PubMed - indexed for MEDLINE]Related articles

Tissue-specific effects of sulfonylureas: lessons from studies of cloned K(ATP) channels.

Ashcroft FM, Gribble FM.

J Diabetes Complications. 2000 Jul-Aug;14(4):192-6. Review.PMID: 11004427 [PubMed - indexed for MEDLINE]Related articles

Sulfonylurea receptors type 1 and 2A randomly assemble to form heteromeric KATP channels of mixed subunit composition.

Chan KW, Wheeler A, Csanády L.

J Gen Physiol. 2008 Jan;131(1):43-58. Epub 2007 Dec 17.PMID: 18079561 [PubMed - indexed for MEDLINE]Related articlesFree article

Sulfonylurea and K(+)-channel opener sensitivity of K(ATP) channels. Functional coupling of Kir6.2 and SUR1 subunits.

Koster JC, Sha Q, Nichols CG.

J Gen Physiol. 1999 Aug;114(2):203-13.PMID: 10435998 [PubMed - indexed for MEDLINE]Related articlesFree article

The effects of mitiglinide (KAD-1229), a new anti-diabetic drug, on ATP-sensitive K+ channels and insulin secretion: comparison with the sulfonylureas and nateglinide.

Sunaga Y, Gonoi T, Shibasaki T, Ichikawa K, Kusama H, Yano H, Seino S.

Eur J Pharmacol. 2001 Nov 9;431(1):119-25.PMID: 11716850 [PubMed - indexed for MEDLINE]Related articles

Functional coupling between sulfonylurea receptor type 1 and a nonselective cation channel in reactive astrocytes from adult rat brain.

Chen M, Dong Y, Simard JM.

J Neurosci. 2003 Sep 17;23(24):8568-77.PMID: 13679426 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of repaglinide on cloned beta cell, cardiac and smooth muscle types of ATP-sensitive potassium channels.

Dabrowski M, Wahl P, Holmes WE, Ashcroft FM.

Diabetologia. 2001 Jun;44(6):747-56.PMID: 11440368 [PubMed - indexed for MEDLINE]Related articles

Regulation of cloned ATP-sensitive K channels by adenine nucleotides and sulfonylureas: interactions between SUR1 and positively charged domains on Kir6.2.

John SA, Weiss JN, Ribalet B.

J Gen Physiol. 2001 Oct;118(4):391-405.PMID: 11585851 [PubMed - indexed for MEDLINE]Related articlesFree article

Selectivity of repaglinide and glibenclamide for the pancreatic over the cardiovascular K(ATP) channels.

Stephan D, Winkler M, Kühner P, Russ U, Quast U.

Diabetologia. 2006 Sep;49(9):2039-48. Epub 2006 Jul 25.PMID: 16865362 [PubMed - indexed for MEDLINE]Related articles

Pharmacological modulation of K(ATP) channels.

Gribble FM, Reimann F.

Biochem Soc Trans. 2002 Apr;30(2):333-9. Review.PMID: 12023875 [PubMed - indexed for MEDLINE]Related articles

Nateglinide, a D-phenylalanine derivative lacking either a sulfonylurea or benzamido moiety, specifically inhibits pancreatic beta-cell-type K(ATP) channels.

Chachin M, Yamada M, Fujita A, Matsuoka T, Matsushita K, Kurachi Y.

J Pharmacol Exp Ther. 2003 Mar;304(3):1025-32.PMID: 12604678 [PubMed - indexed for MEDLINE]Related articlesFree article

Sulfonylurea receptor 1 mutations that cause opposite insulin secretion defects with chemical chaperone exposure.

Pratt EB, Yan FF, Gay JW, Stanley CA, Shyng SL.

J Biol Chem. 2009 Mar 20;284(12):7951-9. Epub 2009 Jan 16.PMID: 19151370 [PubMed - indexed for MEDLINE]Related articles

Analysis of two KCNJ11 neonatal diabetes mutations, V59G and V59A, and the analogous KCNJ8 I60G substitution: differences between the channel subtypes formed with SUR1.

Winkler M, Lutz R, Russ U, Quast U, Bryan J.

J Biol Chem. 2009 Mar 13;284(11):6752-62. Epub 2009 Jan 12.PMID: 19139106 [PubMed - indexed for MEDLINE]Related articles

Adenosine triphosphate-sensitive potassium (K(ATP)) channel activity is coupled with insulin resistance in obesity and type 2 diabetes mellitus.

Wasada T.

Intern Med. 2002 Feb;41(2):84-90. Review.PMID: 11868613 [PubMed - indexed for MEDLINE]Related articlesFree article